𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Older donors: Mounting risks for the hepatitis C–infected liver transplant recipient?

✍ Scribed by Rosa M. Valadao; Norah A. Terrault

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
78 KB
Volume
15
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

✦ Synopsis

The imbalance between the number of available organs and those in need of transplantation underlies the continued impetus to find new ways to expand the donor pool. In the past decade, the use of extended criteria donors (ECDs) has grown. 1 Of the many recognized categories of ECDs, older donors, defined by a donor age of over 40 years, are the most prevalent type. The proportion of older donors has increased significantly over the past decade. In 1995, approximately 20% of donors were over the age of 50 years, whereas in 2005, this proportion had increased to nearly 35% [http:// www.unos.org (accessed February 2009)]. It is well recognized that older donor age is a risk factor for early

📜 SIMILAR VOLUMES

Outcomes in hepatitis C virus–infected r
Outcomes in hepatitis C virus–infected recipients of living donor vs. deceased donor liver transplantation
✍ Norah A. Terrault; Mitchell L. Shiffman; Anna S.F. Lok; Sammy Saab; Lan Tong; Ro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

In this retrospective study of hepatitis C virus (HCV)-infected transplant recipients in the 9-center Adult to Adult Living Donor Liver Transplantation Cohort Study, graft and patient survival and the development of advanced fibrosis were compared among 181 living donor liver transplant (LDLT) recip

Rimantadine for treatment of hepatitis C
Rimantadine for treatment of hepatitis C infection in liver transplant recipients
✍ Sherman, Kenneth E. ;Sickler, Joelle ;Aranda-Michel, Jaime ;Weber, Frederick L. 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 61 KB 👁 2 views

Hepatitis C recurrence after liver transplantation is a serious problem, leading to increased graft loss and morbidity in some individuals. Treatment with interferon and other agents is controversial and not highly efficacious. The use of an effective antiviral agent to reduce or eliminate viral bur

Impact of the donor risk index on the ou
Impact of the donor risk index on the outcome of hepatitis C virus–positive liver transplant recipients
✍ Daniel G. Maluf; Erick B. Edwards; R. Todd Stravitz; H. Myron Kauffman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 2 views

We have investigated the impact of the donor risk index (DRI) on the outcome of hepatitis C virus (HCV)-infected patients undergoing liver transplantation (LTx). Retrospective analysis was performed from the Organ Procurement and Transplantation Network database (January 1, 2000 to June, 2006). The

Living donor liver transplantation for h
Living donor liver transplantation for hepatitis C-related cirrhosis: No difference in histological recurrence when compared to deceased donor liver transplantation recipients
✍ Linsheng Guo; Mauricio Orrego; Hector Rodriguez-Luna; Vijiyan Balan; Thomas Byrn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

The question of possible earlier and more aggressive recurrence of hepatitis C virus (HCV) infection after living donor liver transplantation (LDLT) compared to deceased donor liver transplantation (DDLT) remains unanswered. To address this issue we retrospectively reviewed virological, histological

Prospective validation of a noninvasive
Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus–infected liver transplant recipients
✍ Salvador Benlloch; Laura Heredia; Claudia Barquero; José-Miguel Rayón; Ramón Pin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

We previously developed a mathematical model, the Hospital Universitario La Fe (HULF) index, as an alternative to protocol liver biopsy (PLB) to estimate significant fibrosis (SF) in patients who underwent liver transplantation (LT) for liver damage caused by chronic HCV infection. In the present st

Hepatitis G virus co-infection does not
Hepatitis G virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients
✍ S J Cotler; D R Gretch; M P Bronner; H Tateyama; M J Emond; C dela Rosa; J D Per 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

The clinical significance of HGV infection is uncertain. ## Although hepatitis G virus infection (HGV) is usually Hepatitis G viremia has been documented in patients with asymptomatic, it has been associated with mild hepatic injury. acute hepatitis 1,6,7 and can persist for years, 1,5-7 althoug